InvestorsHub Logo
Followers 31
Posts 901
Boards Moderated 0
Alias Born 12/23/2009

Re: BioBS2012 post# 269800

Monday, 08/08/2016 1:47:01 PM

Monday, August 08, 2016 1:47:01 PM

Post# of 345957
Thanks Bio,it is actually interesting to read his profile https://www.linkedin.com/in/bruce-freimark-6b59001

Ph.D. experienced with major pharmaceutical and biotechnology research management in cancer and inflammation discover/development research groups with an emphasis in human monoclonal therapy, protein biologics, small molecules and antibody-based tumor imaging; cell-based immunological assays; in vivo preclinical cancer and inflammation models, target validation, pharmacokinetics, toxicokinetics and toxicology assessment of biotherapeutics. coordinating external scientific collaborations, technology assessment and developing corporate partnerships. Experience in writing preclinical sections of INDs, IBs, presentation of data to the FDA, patents, DOD/SBIR/STTR grants, and peer-reviewed manuscripts.

Specialties: Pre-clinical development, discovery and translational research in human antibody therapeutics, small molecules, cancer, gene therapy, inflammation, executive management of pre-clinical research groups from product discovery, development and submission of INDs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News